August 7, 2023 – SEKISUI Diagnostics announces the launch of the OSOM COVID-19 Antigen Home Test to diagnose COVID-19 at home.
The OSOM COVID-19 Antigen Home Test is a lateral flow immunoassay device intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2 virus. As with other OSOM Rapid Tests, it is made in the USA and supported by a highly skilled technical support team of medical technologists/professionals.
“We are excited to be able to provide consumers with more tools to help diagnose COVID-19 in a fast, easy-to-use format that can be purchased over the counter. This supports our goal of bringing diagnostics to where they are needed most, which in this case is at home, so people do not have to travel to medical facilities and can treat or quarantine quickly”, said Erica Blight, VP of Client Services, Clinical Research & Marketing.
SEKISUI Diagnostics is a well-known provider of many rapid testing solutions to the professional market through a portfolio of point-of-care tests under the OSOM and Acucy® brands. These simple, high performing tests have provided flexibility to healthcare professionals for decades and are now being brought to the home testing market.
“Our entrance into the home testing market is another way we are providing solutions to enhance life with science to improve the health of all people. We understand home testing is a valuable tool and becoming more accepted and necessary, especially when we are experiencing significant waves of respiratory infections as we have seen in previous seasons”, said Bob Schruender, President & CEO.